ImpediMed Limited (IPD) Founded and headquartered in Brisbane, Australia with US and European operations, ImpediMed is a medical technology company that uses bioimpedance spectroscopy (BIS) technology to generate powerful data to maximise patient health. ImpediMed produces the SOZO Digital Health Platform, which is FDA-cleared, CE-marked, and ARTG listed for multiple indications, including lymphoedema, heart failure, and protein calorie malnutrition and sold in select markets globally.